Cong Claire Xu, SVP, Clinical Development at NovaBridge Biosciences (NBP), sold 3,494 shares at $3.94 ($14K) on 2026-06-01, disclosed to the SEC on 2026-06-02.
Open-market sale of $14k NBP by SVP, Clinical Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.